Biobanking for OVCA (Ovarian Cancer) - Clinical Trial

What is the Purpose of this Study?

We are doing this study to collect data, liquid biopsies (blood and urine), and cancer specimens from women with primary epithelial ovarian, peritoneal, or tubal cancer. We are using this information and these samples to create a biobank that might identify future therapeutic targets and help develop new therapies for these types of cancer.

What is the Condition Being Studied?

Stage III or IV Primary Epithelial Ovarian, Peritoneal, or Tubal Cancer

Who Can Participate in the Study?

Adults ages 18+ who:

  • Have a diagnosis of primary epithelial ovarian, peritoneal, or tubal cancer
  • Have Stage III or IV disease, or recurrent disease
  • Are eligible for treatment with chemotherapy or have already received chemotherapy

For more information about this study, please contact the study team at sarah.linhart@duke.edu.

Age Group
Adults

What is Involved?

If you choose to join this study, we will ask your permission to let us save some samples that you've already provided so we can use them for research. We will also schedule you to have a blood draw approximately every 3 months.

Study Details

Full Title
Biobanking for Longitudinal Monitoring of Ovarian Cancer
Principal Investigator
Gynecologic Oncologist
Protocol Number
IRB: PRO00109365
Enrollment Status
Open for Enrollment